ASCO GU 2024: Updated Results from AVENANCE – Real-World Effectiveness of Avelumab in Patients with Advanced Urothelial Carcinoma
This article presents updated insights from the AVENANCE study about the role of avelumab in advanced urothelial carcinomas.